Table 1:
Clinical characteristics of the patients
| Variable | ICU (+) (n: 63) | ICU (−) (n: 86) | p-value |
|---|---|---|---|
|
| |||
| Age, years, mean (SD) | 63.9 (15.0) | 53.1 (15.6) | < 0.001 |
|
| |||
| Female sex, n (%) | 26 (41.3) | 35 (40.7) | 1 |
|
| |||
| Comorbidities, n (%) | |||
| Hypertension | 38 (60.3) | 34 (39.6) | 0.02 |
| Diabetes mellitus | 22 (34.9) | 22 (25.6) | 0.29 |
| Coronary artery disease | 22 (34.9) | 11 (12.8) | 0.003 |
| Solid organ malignancy | 13 (20.6) | 19 (22.1) | 0.99 |
| Kidney disease | 13 (20.6) | 10 (11.6) | 0.20 |
| Cardiac failure | 14 (22.2) | 6 (7.0) | 0.01 |
| Chronic lung disease | 12 (19.0) | 7(8.1) | 0.08 |
| Hematologic malignancy | 4 (6.3) | 7(8.1) | 0.76 |
| Rheumatologic disease | 4 (6.3) | 3 (3.5) | 0.46 |
| Cerebrovascular disease | 2 (3.2) | 3 (3.5) | 1 |
| Peripheric arterial disease | 1 (1.6) | 1 (1.2) | 1 |
| Dementia | 2 (3.2) | 0 (0.0) | 0.18 |
| Liver disease | 0 (0.0) | 2(2.3) | 0.50 |
|
| |||
| Immunocompromised, n (%) | 12 (19.0) | 16 (18.6) | 1 |
|
| |||
| COVID-19 vaccination history, n (%) | 14 (22.2) | 8(9.3) | 0.05 |
|
| |||
| Age-adjusted Charlson comorbidity index, median (IQR) | 2 (1–3) | 1 (0–1) | < 0.001 |
|
| |||
| Steroid treatment (Minimum 6 mg/day dexamethasone), n (%) | 51 (81.0) | 23 (26.7) | < 0.001 |
|
| |||
| Hospital LOS, days, median (IQR) | 15 (10.5–31.5) | 10 (6–14.75) | < 0.001 |
|
| |||
| In-hospital mortality, n (%) | 19 (30.2) | 1 (1.2) | < 0.001 |
Abbreviations: ICU, Intensive care unit; LOS, Length of stay; IQR, Interquartile range